PresentationWelcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Tessa Romero, and I'm one of the senior biotech analysts here at JPMorgan. We're pleased to welcome our next presenting company, Lexeo Therapeutics, to kick off our Wednesday. And presenting on behalf of the company, we have CEO, Nolan Townsend. Nolan, over to you.Thank you, Tess. It's great to be here, and thanks, everyone, for coming. We're going to start with a short video to give a flavor of the type of diseases ...